Maintenance Notice (3:30 - 10:00 AM December 21, 2024 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Product Document Searching Made Easy by 2D Code! | TCI Life Science News December 2024 | [TCIPracticalExample] Reduction of Amide Group Using... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 21679-14-1 | Product Number: F0658
Fludarabine
×
![]()
×
Purity: >98.0%(T)(HPLC)
Synonyms:
- 9-β-D-Arabinofuranosyl-2-fluoroadenine
- 9-β-D-Arabinofuranosyl-2-fluoro-9H-purin-6-amine
- 2-Fluoroadenine Arabinosid
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 250MG |
$50.00
|
9 | 12 | Contact Us | |
| 1G |
$148.00
|
4 | 7 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | F0658 |
| Purity / Analysis Method | >98.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__0H__1__2FN__5O__4 = 285.24 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Hygroscopic |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image), 250MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 21679-14-1 |
| Reaxys Registry Number | 1225932 |
| PubChem Substance ID | 468591803 |
| Merck Index (14) | 4126 |
| MDL Number | MFCD00132942 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation [a]20/D | +12.0 to +18.0 deg(C=0.1, ethanol) |
Properties (reference)
| Melting Point | 260 °C |
| Specific Rotation | 18° (C=0.1,EtOH) |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | AU6207000 |
Transport Information:
| H.S.code* | 2934.99-000 |
Application
Fludarabine (F-ara-A): An Antimetabolite Antineoplastic Nucleoside
Fludarabine (F-ara-A), an antimetabolite antineoplastic nucleoside, is a 2-fluorinated nucleoside analog of the antiviral agent vidarabine (ara-A) [V0098] that is relatively resistant to deamination by adenosine deaminase. F-ara-A is rapidly phosphorylated intracellularly by deoxycytidine kinase to the active triphosphate, 2-fluoro-ara-ATP (F-ara-ATP). The active metabolite acts by inhibiting DNA and RNA polymerases thus preventing DNA and RNA syntheses in proliferating cells. In clinical, its monophosphate, F-ara-AMP, is used for the treatment of chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin's lymphoma. (The product is for research purpose only.)
References
- Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity
- Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies (a review)
- Cellular and clinical pharmacology of fludarabine (a review)
- Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity
- A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.